Vivos System
Commercial- Indications
- Obstructive sleep apnea, Sleep disordered breathing, Snoring
Company intelligence / Profile preview
Vivos Therapeutics has developed the first FDA-cleared non-surgical oral appliance for treating all severities of OSA in adults and moderate-to-severe OSA in children. Clinical results show significant improvement or resolution of OSA symptoms for many patients. Over 45,000 patients have been treated worldwide by more than 2,000 trained dentists. Peer-reviewed studies indicate that up to one out of four patients experienced complete resolution of their OSA symptoms with no persistent safety issues reported[5][7][8].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivos Therapeutics.